Guest guest Posted December 27, 2008 Report Share Posted December 27, 2008 12/26/08 Please feel free to forward to those who may be in a position to support this new Foundation. Thanks, and Happy New Year to all!! ********************************* Change is coming from a chemistry lab in Lexington, Kentucky. In 2008, after years of work, Dr. Boyd Haley and his team put the finishing touches on OSR#1, a dietary antioxidant which helps maintain a healthy reduced glutathione level in the body. Boyd's company, CTI Science Inc., has successfully brought OSR#1 to market. In the process, CTI Science Inc. has proven OSR#1 to be without toxic effects and has initially studied its effectiveness with regard to helping maintain a healthy gulatione level. A healthy glutathione level is likely the first step in developing an overall protocol for maintaining good health, but there is more to be done. You are receiving this email in part due to your great work within the autism community to advance biomedical treatments. You are letting the world know that improvement and recovery are possible. As people with ASD often have nutritional deficiencies and are prone to a low glutathione level, and as OSR#1 helps maintain a healthy glutathione level in people with sub-optimal diets, individuals with ASD may benefit from OSR#1. CTI Science Foundation will help fund clinical trials to document the best ways to maintain healthy glutathione levels. The foundation will seek to provide OSR#1 to those who would potentially benefit from it worldwide regardless of their ability to pay. These initial projects will require private funding through the generosity of concerned citizens and we ask that you consider a tax deductible donation before the year's end to CTI Science Foundation. Those who donate in 2008 will be remembered as Founding Donors. The CTI Science, Inc. and CTI Science Foundation websites are set to launch in early 2009. If you are in a position to contribute to this effort, please send a check before the end of this year (checks mailed in 2008 are deductible for 2008) to: CTI Science Foundation P.O. Box 813 New York, NY 10014 Please feel free to forward this email to others - both inside and outside the autism community - seeking worthy foundations to support as part of their 2008 tax planning. If you have any questions, or for wire transfer instructions, please contact me privately at kevinbarry239@.... Wishing you and your family Happy Holidays and a Happy New Year, Barry President and Chairman of the Board CTI Science Foundation PS- This message was featured on the Age of Autism blog: http://www.ageofautism.com/2008/12/cti-science-foundation-where-autism-treatment\ -meets-generosity.html Quote Link to comment Share on other sites More sharing options...
Guest guest Posted December 27, 2008 Report Share Posted December 27, 2008 I wish I could get a hold of that Dr. Boyd Haley, and thank him for his work. He is remarkable and I hope he is the one to save us. He is a hero in my eyes..There are many more heroes, all of you that have taught me so much in such a short time. Thank you all and I am wishing your families recovery in the new year.. Love and many, many blessings, Candyce OT: CTI Science foundation seeks Founding Donors 12/26/08Please feel free to forward to those who may be in a position tosupport this new Foundation. Thanks, and Happy New Year to all!! *********************************Change is coming from a chemistry lab in Lexington, Kentucky.In 2008, after years of work, Dr. Boyd Haley and his team put thefinishing touches on OSR#1, a dietary antioxidant which helps maintaina healthy reduced glutathione level in the body.Boyd's company, CTI Science Inc., has successfully brought OSR#1 tomarket. In the process, CTI Science Inc. has proven OSR#1 to bewithout toxic effects and has initially studied its effectiveness withregard to helping maintain a healthy gulatione level. A healthyglutathione level is likely the first step in developing an overallprotocol for maintaining good health, but there is more to be done. You are receiving this email in part due to your great work within theautism community to advance biomedical treatments. You are lettingthe world know that improvement and recovery are possible. As peoplewith ASD often have nutritional deficiencies and are prone to a lowglutathione level, and as OSR#1 helps maintain a healthy glutathionelevel in people with sub-optimal diets, individuals with ASD maybenefit from OSR#1.CTI Science Foundation will help fund clinical trials to document thebest ways to maintain healthy glutathione levels. The foundation willseek to provide OSR#1 to those who would potentially benefit from itworldwide regardless of their ability to pay.These initial projects will require private funding through thegenerosity of concerned citizens and we ask that you consider a taxdeductible donation before the year's end to CTI Science Foundation. Those who donate in 2008 will be remembered as Founding Donors. The CTI Science, Inc. and CTI Science Foundation websites are set tolaunch in early 2009.If you are in a position to contribute to this effort, please send acheck before the end of this year (checks mailed in 2008 aredeductible for 2008) to:CTI Science FoundationP.O. Box 813New York, NY 10014Please feel free to forward this email to others - both inside andoutside the autism community - seeking worthy foundations to supportas part of their 2008 tax planning.If you have any questions, or for wire transfer instructions, pleasecontact me privately at kevinbarry239gmail.Wishing you and your family Happy Holidays and a Happy New Year, BarryPresident and Chairman of the BoardCTI Science FoundationPS- This message was featured on the Age of Autism blog:http://www.ageofautism.com/2008/12/cti-science-foundation-where-autism-treatment-meets-generosity.html Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.